World Health Organization Issues Alert Over Severe Scarcity of Weight-Loss Jabs

Under a tenth of people that would benefit from weight-loss injections such as Wegovy have access to them, states the global health agency as it issues its initial recommendations on the therapies.

Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is urging increased and just availability to this class of drugs.

Based on estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 unless action is taken.

"The new guidelines acknowledges that excess weight is a lifelong illness that can be treated with comprehensive and ongoing support," said its chief Tedros Adhanom Ghebreyesus.

Substantial prices, insufficient output, and distribution challenges are significant barriers to universal access to the treatments that can assist patients in reducing considerable body mass, explains the body.

Weight-Loss Drug Supply Crisis

Even in the present most favorable case, the production of such drugs would only suffice for about 100 million people – less than 10% of eligible patients, as stated by the health organization.

The recommendation encourages countries and companies to expand availability, by approaches such as licensing agreements.

Exclusive production rights on a key compound – the core component of the drug Wegovy – is set to lapse in several countries in 2026.

How Obesity Injections Work

The injections mimick a biological compound to slow digestion, suppress the appetite and increase the sense of being full so users consume fewer calories.

Patients usually begin shedding pounds within a few weeks of starting on the regular doses.

Evidence points to people may regain a significant portion after a year of halting the drug, when their normal hunger come back.

Being carrying excess weight increases your risk for experiencing health problems, including diabetes, cardiovascular issues, brain attack, and certain cancers.

Excess weight impacts individuals in all nations and was linked to over three and a half million deaths worldwide in 2024, according to the WHO.